Skip to content

Clinical trials

Completed Observational Acquired Immunodeficiency Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Observational Status: Completed Clear all

351 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20015
20025
20039
20049
200513
20069
200713
200817
200918
201015
201119
201216
201316
201418
201514
201610
201722
201817
201923
20209
202111
202210
20232
20245

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed351

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)28
National Cancer Institute (NCI)14
Columbia University13
ViiV Healthcare12
National Heart, Lung, and Blood Institute (NHLBI)11
University of North Carolina, Chapel Hill9
Massachusetts General Hospital7
AbbVie (prior sponsor, Abbott)6
National Institutes of Health Clinical Center (CC)6
University of California, San Diego6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome351
HIV Infections116
Hepatitis C20
Infections13
Tuberculosis12
Neoplasms11
Cardiovascular Diseases9
HIV Seropositivity9
Heart Diseases8
Hepatitis B8

Trials

Showing 1 to 25 of 351. Each trial links to its page on Pharma Observatory.

251 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.